InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Akamine Scott. Director active across 1 company, notably Cerevel Therapeutics Holdings, Inc.. Aggregated, 5 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €392k. Activity tracked since 8 August 2022. The latest transaction was disclosed on 5 December 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
5 of 5 declarations